Since Flt3L-mediated expansion of Batf3-dependent DCs boosts tumor-specific CD8+ T cells,7 we tested whether Flt3L effect on cDC1s could be affected by DNGR-1 in the context of tumors. Here, CLEC9A is linked to neoplasm.